US5624685A
Expired / Lapsed
US
⏱️ 0.0 years remaining
High polymer gel and vascular lesion embolizing material comprising the same
Assignee: Terumo Corp
•
Filing: 1995-04-03
•
Granted: 1997-04-29
•
Expires: 2015-04-03
Abstract
Abstract The improved vascular lesion embolizing material comprises a high-polymer gel capable of absorbing water in an amount of 10 ml/g and more. The high-polymer gel is preferably such as is produced by first permitting a solution containing a water-soluble high polymer to be precipitated in a solution containing polyvalent cation, said high polymer having a plurality of monovalent anionic functional groups, and then immersing the resulting precipitate in a salt solution. The material will swell upon contact with blood and is capable of embolizing a focal lesion in a blood vessel without causing any adverse effects on the living body. The swell time can be shortened if the embolizing material is made of a high-polymer gel that has been treated with a salt solution after precipitation.
Inventors
- 👤 Toru Takahashi
- 👤 Hideki Nakamura
- 👤 Katsuya Goto
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-25 19:54
CPC Classifications
A; A61; A61L; A61L31/00; A61L31/04; A61L31/042; A61P; A61P7/00; A61P7/04; A61P9/00; A61L2430/00; A61L2430/36
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
134 words
A method for treating a vascular lesion using a vascular lesion-embolizing material, said method comprising the steps of: applying the vascular lesion-embolizing material in the interior of the vascular lesion to bring said embolizing material into contact with blood flowing through the vascular lesion, said vascular lesion-embolizing material comprising a dried water-absorbent polymer gel capable of absorbing water in an amount of at least 10 ml/g when measured by dipping the dry polymer gel in a physiological saline; and allowing said embolizing material to swell thereby completing the embolization of the vascular lesion; said polymer gel being produced by precipitating a solution containing a water-soluble polymer of an alkali metal salt of alginic acid in a solution containing a polyvalent cation, immersing the resulting precipitate in a salt solution, and then drying the precipitate.
Claim 2
Independent Claim
134 words
A method for treating a vascular lesion using a vascular lesion-embolizing material, said method comprising the steps of: applying the vascular lesion-embolizing material in the interior of the vascular lesion to bring said embolizing material into contact with blood flowing through the vascular lesion, said vascular lesion-embolizing material comprising a dried water-absorbent polymer gel capable of absorbing water in an amount of at least 10 ml/g when measured by dipping the dry polymer gel in a physiological saline; and allowing said embolizing material to swell thereby completing the embolization of the vascular lesion; said polymer gel being produced by precipitating a solution containing a water-soluble polymer of an alkali metal salt of alginic acid in a solution containing a polyvalent cation, immersing the resulting precipitate in a salt solution, and then drying the precipitate.
Claim 3
Dependent Claim
16 words
The method according to claim 1, wherein said embolizing material further comprises an X-ray contrast medium.
Claim 4
Dependent Claim
14 words
The method according to claim 1, wherein said polyvalent cation is a calcium ion.
Claim 5
Dependent Claim
15 words
The method according to claim 1, wherein said polymer gel is bound with a binder.
Claim 6
Dependent Claim
19 words
The method according to claim 1, wherein said vascular lesion is in a cerebrum, spine, abdominal port or limb.
Claim 7
Independent Claim
156 words
A method for treating a vascular lesion using a vascular lesion-embolizing material, said method comprising the steps of: applying the vascular lesion-embolizing material in the interior of the vascular lesion to bring said embolizing material into contact with blood flowing through the vascular lesion, said vascular lesion-embolizing material comprising a dried water-absorbent polymer gel capable of absorbing water in an amount of at least 10 ml/g when measured by dipping the dry polymer gel in a physiological saline, and a blood coagulating substance; and allowing said embolizing material to swell thereby completing the embolization of the vascular lesion and, simultaneously, to dissolve said blood coagulating substance thereby coagulating blood absorbed in the swollen embolizing material; said polymer gel being produced by precipitating a solution containing a water-soluble polymer of an alkali metal salt of alginic acid in a solution containing a polyvalent cation, immersing the resulting precipitate in a salt solution, and then drying the precipitate.
Claim 8
Independent Claim
156 words
A method for treating a vascular lesion using a vascular lesion-embolizing material, said method comprising the steps of: applying the vascular lesion-embolizing material in the interior of the vascular lesion to bring said embolizing material into contact with blood flowing through the vascular lesion, said vascular lesion-embolizing material comprising a dried water-absorbent polymer gel capable of absorbing water in an amount of at least 10 ml/g when measured by dipping the dry polymer gel in a physiological saline, and a blood coagulating substance; and allowing said embolizing material to swell thereby completing the embolization of the vascular lesion and, simultaneously, to dissolve said blood coagulating substance thereby coagulating blood absorbed in the swollen embolizing material; said polymer gel being produced by precipitating a solution containing a water-soluble polymer of an alkali metal salt of alginic acid in a solution containing a polyvalent cation, immersing the resulting precipitate in a salt solution, and then drying the precipitate.
Claim 9
Dependent Claim
16 words
The method according to claim 6, wherein said embolizing material further comprises an X-ray contrast medium.
Claim 10
Dependent Claim
14 words
The method according to claim 6, wherein said polyvalent cation is a calcium ion.
Claim 11
Dependent Claim
15 words
The method according to claim 6, wherein said polymer gel is bound with a binder.
Claim 12
Dependent Claim
19 words
The method according to claim 6, wherein said vascular lesion is in a cerebrum, spine, abdominal port or limb.
References Cited (Backward Citations)
US3640741A
Cited
US3850838A
Cited
US4347261A
Cited
US4401456A
Cited
US4393048A
Cited
US4501834A
Cited
US4795741A
Cited
US4948575A
Cited
US5356654A
Cited
US5144016A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2000-04-28 | 2000-10-28 | 2001-04-29 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2004-04-28 | 2004-10-28 | 2005-04-29 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2008-04-28 | 2008-10-28 | 2009-04-29 | $7700.00 | Window Closed / Lapsed |